HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune Encephalitis.

AbstractBACKGROUND AND OBJECTIVES:
CSF in antibody-defined autoimmune encephalitis (AE) subtypes shows subtype-dependent degrees of inflammation ranging from rare and often mild to frequent and often robust. AEs with NMDA receptor antibodies (NMDAR-E) and leucine-rich glioma-inactivated protein 1 antibodies (LGI1-E) represent opposite ends of this spectrum: NMDAR-E with typically frequent/robust and LGI1-E with rare/mild CSF inflammation. For a more in-depth analysis, we characterized CSF findings in acute, therapy-naive NMDAR-E and LGI1-E in a multicentric, retrospective, cross-sectional setting.
METHODS:
Eighty-two patients with NMDAR-E and 36 patients with LGI1-E from the GErman NEtwork for Research of AuToimmune Encephalitis (GENERATE) with lumbar puncture within 90 days of onset and before immunotherapy were included. CSF parameters comprised leukocytes, oligoclonal bands (OCBs), and CSF/serum ratios for albumin, immunoglobulin G (IgG), A (IgA), and M (IgM), the latter 3 converted to Z scores according to Reiber formulas. The MRZ reaction was tested in 14 patients with NMDAR-E and 6 patients with LGI1-E, respectively.
RESULTS:
CSF was abnormal in 94% of NMDAR-E but only in 36% of LGI1-E patients. Robust quantitative intrathecal immunoglobulin synthesis (IIS, IgG > IgM >> IgA) was characteristic for NMDAR-E, but absent in LGI-E. In NMDAR-E, CSF leukocytes were higher when IIS was present or more pronounced. In addition, in NMDAR-E, CSF leukocytes were lower and IIS occurred less often and if so to a lesser degree at older age. Patients with NMDAR-E with severe functional impairment more often had positive OCBs. In CSF obtained later than 3 weeks of onset, leukocytes were lower. In parallel, the correlation of leukocytes with IIS disappeared as IIS was partially independent of disease duration. The MRZ reaction was positive in 5 (36%) patients with NMDAR-E. All these associations were completely absent in LGI1-E. Here, younger patients showed more blood-CSF barrier dysfunction. In LGI1-E, but not in NMDAR-E, the blood-CSF barrier was more dysfunctional when CSF leukocytes were higher.
DISCUSSION:
NMDAR-E and LGI-E differ in their typical extent of CSF inflammation. In addition, the patterns formed by the different inflammatory CSF parameters and their relationship with disease severity, age, and disease duration are subtype-characteristic. Moreover, signs for multiple sclerosis-like chronic inflammation are present in a subgroup of patients with NMDAR-E. These CSF patterns might be markers for the different immunopathogeneses of LGI1-E and NMDAR-E.
AuthorsMarc Dürr, Gunnar Nissen, Kurt-Wolfram Sühs, Philipp Schwenkenbecher, Christian Geis, Marius Ringelstein, Hans-Peter Hartung, Manuel A Friese, Max Kaufmann, Michael P Malter, Marie Madlener, Franziska S Thaler, Tania Kümpfel, Makbule Senel, Martin G Häusler, Hauke Schneider, Florian Then Bergh, Christoph Kellinghaus, Uwe K Zettl, Klaus-Peter Wandinger, Nico Melzer, Catharina C Gross, Peter Lange, Jens Dreyhaupt, Hayrettin Tumani, Frank Leypoldt, Jan Lewerenz, German Network for Research on Autoimmune Encephalitis
JournalNeurology(R) neuroimmunology & neuroinflammation (Neurol Neuroimmunol Neuroinflamm) Vol. 8 Issue 6 (11 2021) ISSN: 2332-7812 [Electronic] United States
PMID34697224 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Chemical References
  • Autoantibodies
  • Intracellular Signaling Peptides and Proteins
  • LGI1 protein, human
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis (cerebrospinal fluid)
  • Autoantibodies (cerebrospinal fluid)
  • Autoimmune Diseases of the Nervous System (cerebrospinal fluid)
  • Encephalitis (cerebrospinal fluid)
  • Female
  • Humans
  • Intracellular Signaling Peptides and Proteins (immunology)
  • Male
  • Middle Aged
  • Prospective Studies
  • Registries
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: